6 New Approved Drugs for Primary Care: Q1 2023

From type 2 diabetes to migraine, we have picked the top 6 FDA-approved drugs every primary care physician should know about from the first quarter.

At the close of the first quarter of a new year, Patient Care Online has compiled a list of 6 new US Food and Drug Administration (FDA)-approved drugs for conditions that are often seen in primary care. Scroll through the slides below to find details on the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the acute treatment of migraine with or without aura in adults; a novel fixed dose combination of albuterol and budesonide for the treatment of asthma; and 4 more.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
© 2023 MJH Life Sciences

All rights reserved.